How to Reach Our Staff?

The Institute for Molecular Medicine - Headquarters

Office of the President

31677 Virginia Way P.O. Box 9355

South Laguna Beach, CA 92652

Telephone: (949) 715-5978

 

Department of Immunology
16371 Gothard Street H
Huntington Beach, California 92647-3652, USA
Telephone: (714) 596-7821

Fax: (714) 596-3791
Office Hours: 8:00 am - 5:00 pm

Business Office: mail@immed.org
Send questions to: mail@immed.org
Webmaster jfm.webmaster@immed.org

 




 

IMM – Faculty and Associate Faculty

Garth L. Nicolson, Ph.D.
gnicolson@immed.org

Ph.D. Biochemistry/Cell Biology, University of California San Diego (1970); B.S. Chemistry, University of California Los Angeles (1965)
Founded IMM 1996

Dr. Nicolson is the President, Chief Scientific Officer and a Research Professor at the Institute for Molecular Medicine. He has over 550 scientific and medical publications, several of which are citation classics. He holds 9 U.S. patents. Formerly he was the David Bruton Jr. Chair in Cancer Research, Professor and Chairman, Dept. of Tumor Biology at the University of Texas M. D. Anderson Cancer Center, and he has held various other professorships including Professor of Internal Medicine and Professor of Pathology and Laboratory Medicine at the University of Texas Medical School at Houston and Professor of Comparative Pathology at Texas A & M University. He serves as Editor of two journals ( Clinical & Experimental Metastasis and Journal of Cellular Biochemistry ) and as an Associate Editor of 12 other medical/scientific journals. Dr. Nicolson has held several memberships of advisory and review committees and is currently a member of national and international committees in cancer research and other scientific programs. Besides many other awards, he was honored with the Stephen Paget Award of the Metastasis Research Society, the Outstanding Investigator Award of the National Cancer Institute and the Albert Schweitzer Award in 1998. He is member of various scientific societies and held offices in the American Association for Cancer Research and Metastasis Research Society. Under his supervision 36 postdoctoral fellowships and 17 Ph.D. theses were performed. Dr. Nicolson's interests are in the biochemistry and molecular genetics of cancer progression with particular interests in the areas of metastasis or spread of cancer, paracrine growth factors and invasion enzymes. He is a Colonel (Honorary) of the U. S. Army Special Forces and a U. S. Navy SEAL (Honorary) for his work on Armed Forces and veterans' illnesses. He is also engaged in research on the role of chronic infections in a variety of chronic illnesses, such as Chronic Fatigue Syndrome, Fibromyalgia Syndrome, Rheumatoid Arthritis, Gulf War Illness and various autoimmune diseases.

Complete Curriculum Vitae

Founded IMM 1996



Nancy L. Nicolson, Ph.D.
nnicolson@immed.org

Ph.D. Biophysics/Molecular Biology, Florida State University (1982); M.S. Biochemistry, Nova University, Ft. Lauderdale (1978); Postdoctoral training, Dept. of Physics, University of Texas M. D. Anderson Cancer Center, Houston (1982-1984); Baylor College of Medicine (1987-1991); University of Texas M. D. Anderson Cancer Center, Houston (1989-1996)
Founded IMM 1996

Dr. Nicolson is currently Chief Executive Officer of the Institute for Molecular Medicine, President of the Rhodon Foundation for Biomedical Research, Inc. and Chairman of the Board of International Molecular Diagnostics, Inc. She has published over 40 scientific papers and 26 abstracts from international scientific conferences. She holds one U.S. patent. Besides her other awards, she was honored as Who's Who Woman in the World (1996), the Who's Who Executives in the World (1998), and shared the Albert Schweitzer Award (1998). Dr. Nicolson has been selected to serve on the U.S. Congressional Business Council; she is U.S. Congressional Businesswoman of the Year for 2000, and was awarded the Republican National Committee's Congressional Medal of Honor . Her research interests are focused on regulation and function of eukaryotic genes using specific native nucleoprotein complexes. She is a Colonel (Honorary) of the U. S. Army Special Forces and a U. S. Navy SEAL (Honorary) for her work on Armed Forces and veterans' illnesses. She developed the nucleoprotein gene tracking method as a diagnostic tool. Furthermore, she has worked on the detection and pathogenesis of chronic infections in human.

Complete Curriculum Vitae

Founded IMM 1996

 

Jöerg Haier, M.D., Ph.D.
haier@uni-muenster.de

M.D. Humboldt-University, Berlin, Germany (1991); Ph.D. Humboldt-University, Berlin, Germany (1993); Surgical Residency, Robert-Rössle-Hospital and University Hospital Benjamin Franklin, Free University of Berlin, Germany (1991-1997), Ruprecht-Carls-University Heidelberg (1994).
Dr. Jörg Haier is currently an Assistant Professor of Surgery in the Department of Internal Medicine, and 3Department of Surgery, Wilhelm-University, Munster, Germany, and an Assistant Research Professor at the Institute for Molecular Medicine. He has published 30 peer reviewed scientific papers, 20 abstracts from international conferences and 6 clinical and scientific book chapters. Additionally, he has prepared two surgical videotapes. In his clinical work, he has concentrated on diagnosis and treatment of colorectal cancer and soft tissue sarcomas. His scientific interests are focused on mechanisms required for the organ-specific development of cancer metastases. He is particularly interested in signals that are transmitted into the tumor cells during their adhesion to host organs. At the Institute for Molecular Medicine Dr. Haier works on signal transduction mediated by adhesion molecules of the tumor cell surface during adhesion. Additionally, he is taking part in clinical studies for the evaluation of chronic infections in patients with several chronic diseases.

 

Gajanan Sherbet, Ph.D.
gsherbert@immed.org

Dr. Gajanan Sherbet is Adjunct Professor at the Institute for Molecular Medicine and Reader in Experimental Oncology at the University of Newcastle upon Tyne, England. He is a Fellow of the Royal College of Pathologists, Royal Society of Chemistry and The Institute of Biology, U.K. Dr. Sherbet is a member of the editorial boards of two scientific journals (Pathobiology and Anticancer Research). Dr. Sherbet's major scientific interest is in cancer metastasis. In recent years he has been investigating the role of the calcium binding protein S100A4 in cell proliferation, cancer invasion and metastasis. He is also studying the potential of artificial neural networks for predicting breast cancer progression and prognosis. He has recently demonstrated the potential value of S100A4 as a marker for assessing the progression of breast cancer. He has been published over 200 scientific papers in international journals and has wriiten four books and edited two others, on cancer. His latest work on the genetics of cancer was in collaboration with Dr. M.S. Lakshmi.

Joined IMM 1999.

 

Michael G. Agadjanyan, D.Sc., Ph.D.
magadjanyan@immed.org

D.Sc,, Immunology/Virology, Institute of Viral Preparation, USSR Academy of Science, 1989; Ph.D., Immunology, Institute of Epidemiology & Immunology, USSR Academy of Science, 1980; M.S., Biology, Moscow State University, Moscow, 1976; B.S., Biology, University of Yerevan, Armenia, 1972.

Dr. Agadjanyan is currently Research Professor of Immunology and Virology at the Institute for Molecular Medicine. He was formally a Visiting Professor at the University of Pennsylvania, Phildelphia, PA. He was also previously a Visiting Professor at the Wistar Institute in Philadelphia, and before that a Junior then Senior Scientist at the Gamaleya Institute of the USSR Academy of Science, Moscow. Dr. Agadjanyan has served on several committees and member of several international associations, He has over 60 publications in the areas of cellular immunology and virology. He currently hold two grants from the National Institutes of Health on the immunology and biochemistry of HIV infection and HIV vaccines. His research interests are in the area of immune response to HIV infection and the development of HIV-1 vaccines based on DNA vaccine technology.

Complete Curriculum Vitae

Joined IMM 2000.


Robert Gan, B.Sc.(Med)., Ph.D.
rgan@imd-lab.com

B.Sc.(Med.)., University of Adelaide School of Medicine, Adelaide, South Australia; M.S., University of Southern California, Los Angeles, CA; Ph.D., University of Southern California, Los Angeles, CA.

Dr. Gan is currently the Head of the Department of Microbiology at International Molecular Diagnostics, Inc. and Research Assistant Professor of Microbiology at the Institute for Molecular Medicine. Dr. Gan was previously a Senior Lecturer at the University of Southern California and Professor of Immunology at Immaculate Heart College. He holds certifications as a Clinical Laboratory Scientist, Microbiologist Specialist (National Registry of Microbiologists), Clinical Lab Specialist (NCA), Clinical Laboratory Director (American Board of Bioanalysis), and he is a member of the American Academy of Anti-Aging Medicine, Institute for the Prevention of Diseases of Aging and American Academy of Nutritional Medicine. He was previously laboratory director of certified clinical reference laboratories in Southern California and a Clinical Director for VitaFit Center for Life.

Joined IMM 2000

 

Anahit Ghochikyan, Ph.D.
aghochikyan@immed.org

Ph.D., Molecular Biology, Institute of Biochemistry of the Academy of Sciences of Armenia (1988); M.S., Biochemistry and Genetics, Yerevan State University, Armenia (1984).

Dr. Ghochikyan is currently a Research Assistant Professor Immunology at the Institute for Molecular Medicine. Her research background includes areas of molecular biology and immunology. Dr. Ghochikyan also received training in former USSR (The Institute of Biotechnology), in Israel (Weizmann Institute of Sciences, Rehovot), and in France (the University of Nantes , Nantes ) before coming to the United States . She has published extensively in areas of molecular biology and immunology, having 28 manuscripts in the different peer-review journals. Recently, Dr. Ghochikyan completed a collaboration with scientists from the Institute for Brain Aging and Dementia at the University of California , Irvine . These important studies may lead to the generation of nucleic acid (“naked DNA”) vaccine against Alzheimer's disease (AD). She is a Member of the American Associations of Neuroscience, Immunology, and Microbiology. Her research interests are in the area of development of safe vaccines against cancer and Alzheimer's disease.

Complete Curriculum Vitae

 

John Daily, Brig. General (ret.)

John Daily is a retired U.S. Army Brigadier General with extensive experience in national command authority level organizations and Special Forces operations. His career includes leadership and management in federal, state and local agencies. Gen. Daily is a graduate of the University of New Hampshire in Business administration and Minor political science, of the St. Michael's War College, where he graduated as a M.S. in psychology and counseling. Furthermore, he was trained at the National War College and the John F. Kennedy School of Government at the Harvard University. Gen. Daily is a Senior Military Advisor at the Institute for Molecular Medicine.

Joined IMM 1999.

 

Robert E. Pursley, Lt. General (ret.)

Robert E. Pursley is a retired U.S. Air Force Lieutenant General with extensive experience in international business and management. He is a graduate of the Air Force Academy, and he received a M.B.A. from Harvard University. Lt. Gen. Pursley is the former Military Assistant to the Secretary of Defense and Commander, U.S. Forces Japan and the 5th Air Force. He received several citations while in the U.S. Air Force, including the Legion of Merit, Flying Cross and Air Medal with Clusters. He was formally an Associate Professor of Economics at the Air Force Academy. Since his retirement he has been Executive Vice President of Insilco Corporation and a Partner in J. H. Whitney & Company. He is also Vice Chairman of USAA Financial Services. He is currently a Teaching Fellow at Hartwick College in New York and has served for a number of years as Director of the Arms Control Association. Lt. Gen. Pursley is a Senior Military and Economic Advisor at the Institute for Molecular Medicine.

Joined IMM 2000.

 

Darryl M. See, M.D.

Dr. See is one of the leading physicians in chronic illnesses. He obtained his M.D. degree from the University of California, Irvine and was on staff at this medical school for fellowships in Infectious Diseases and Virology. He is formally an Assistant and then Associate Professor of Medicine at the UCI School of Medicine where he contributed many publications in HIV-AIDS, virus infections, Chronic Fatigue Syndrome and other chronic illnesses. Dr. See is an Adjunct Associate Clinical Professor of Medicine at the Institute for Molecular Medicine.

Joined IMM 2000.

 

David-Xavier Kenney

David-Xavier Kenney has been affiliated with the Institute for Molecular Medicine since 1996 and is currently its military adviser. He jointed the U.S. Marines in 1973 and the U.S. Marine Corps Reserves in 1977. Mr. Kenny is currently an Infantry Gunnery Sergeant in the U.S. Marine Corps Reserves. He attended the University of Maryland and Nathaniel Hawthorne Business College. Mr. Kenney is President of Amitie Sans Frontieres (A.S.F.), South Carolina, and was honored with the Gold Medal of Office for A.S.F. by H.S.H. Prince Albert of Monaco in 1996.

Joined IMM 1996.

 

Richard Ngwenya, M.D.

Dr. Ngwenya is currently the Executive Medical Director of the James Mobb Immune Enhancement Clinics in Harare, Zimbabwe and an Adjunct Clinical Professor at the Institute for Molecular Medicine where he serves as a member of the Board of Directors of the Institute. He was born in Zimbabwe and is a retired military medical officer. Dr. Ngwenya is an expert in the treatment of HIV-AIDS and other chronic illnesses. Dr. Ngwenya is an Adjunct Clinical Professor of Medicine at the Institute for Molecular Medicine.

Joined IMM 1997.

 

Ferre Akbarpour, M.D.

Dr. Akbarpour is currently the Medical Director of the Immune Institute and a member of the Orange County Center for Special Immunology in Huntington Beach, California. She was previously Chief of Staff of the Rushmore Medical Diagnostic Institute (1987-1991). Dr. Akbarpour received her medical degree from Pahlavi University School of Medicine, Shiraz, Iran in 1978, and she was a resident at the Long Beach Veterans Administration Medical Center and a post-graduate and extern at the University of California, Irvine School of Medicine. She is an expert in the area of chronic illnesses, including fatiguing illnesses and autoimmune diseases. Dr. Akbarpour is an Adjunct Clinical Associate Professor at the Institute for Molecular Medicine.

Joined IMM 2000.

 

Isa Odidi, Ph.D.

Dr. Odidi is a graduate of the University of London in Pharmacology. He is currently the CEO of IntelliPharmaceutics, Inc. of Ontario, Canada, and he holds as adjunct professorship at the University of Toronto. Dr. Odidi was born in Nigeria and is a well-known expert on drug time-release technology, having published many papers on the topic. He also holds 13 patent applications in this area and has successfully developed and directed the R&D division of a major pharmaceutical company (Biovail in Canada). Dr. Odidi is an Adjunct Research Professor at the Institute for Molecular Medicine.

Joined IMM 1998.

 

William Rae, M.D.

Dr. Rea is a graduate (B.S., B.A.) of the Otterbein College, Westerville OH, and of the Ohio State University College of Medicine, Columbus, Ohio. He finished his medical training as a Thoracic Surgeon and is furthermore specialized in Environmental Medicine. He is member of numerous medical and scientific societies where he served as Chairman and member of various boards. He has over 120 publications in medical and scientific journals, and he has received several awards during his medical career. At the Institute for Molecular Medicine Dr. Rea is an Adjunct Clinical Professor of Medicine.

Joined IMM 1999.

 

Donald W. Scott, M.S.

Donald Scott is a former Commissioner of the Ontario Teachers' Pension Fund and a former Governor of the Ontario Teachers' Federation. He is a Life Member of the Ontario Secondary School Teacher's Federation. Don Scott holds a Master of Science degree from Guelph University and a Master of Arts from Laurentian University. He is an Adjunct Professor of Science History at the Institute for Molecular Medicine.

Joined IMM 1999.

 

Kenny De Meirleir, M.D.

Dr. De Meirleir is currently Professor of Internal Medicine, The Free University of Brussels, Brussels, Belgium. He is also a Professor of Physiology at The Free University of Brussels. He is also Director of the Fatigue Clinic at The Free University of Brussels. Dr. De Meirlier obtained his M.D. in 1977 from The Free University of Brussels and was a resident in Internal Medicine and in Cardiology. He received the Solvay Prize in 1980 and a NATO research award. He is a member of several editorial boards and associations in Europe, and he has over 390 publications. Dr. De Meirleir has held many administrative positions in Belgium and at The Free University of Brussels. Dr. De. Meirlier is an Adjunct Professor of Medicine at the Institute for Molecular Medicine.

Joined IMM 2000.

 

Oscar Rogers Kruesi, M.D., F.A.C.P.

Dr. Kruesi has a B.S. from the Union College Schenectady, N.Y., and graduated from Cornell University Medical College, New York with the M.D. degree. Currently he is an Associate Professor of Medicine at the Capital University of Integrative Medicine, Washington DC, and is the Medical Director of New Health Initiative, Morristown. He serves in several medical advisory boards and research committees and is currently in private medical practice in New Jersey. Dr. Kruesi is an Adjunct Clinical Professor of Medicine at the Institute for Molecular Medicine.

Joined IMM 1999.

 

Harold W. Clark, Jr., Ph.D.  [In Memory of his Honorable Service - deceased]

Dr. Clark is a graduate of the Rochester Institute of Technology, N.Y., and the College of Wooster, OH. He holds a Ph.D. from the University of Rochester in Biochemistry. During his career at the George Washington University School of Medicine, Washington D.C., he was Director of Research at their Rehabilitation Research & Training Center. He was also Director of Research at the Arthritis Institute of the National Hospital for Orthopedics and Rehabilitation, Arlington, VA, and the Mycoplasma Research Institute, Beverly Hills, FL. Currently he is Vice Chairmen and CEO at the Arthritis Institute. Dr. Clark is member of various professional medical societies, where he serves as a distinct specialist in mycoplasma research. Dr. Clark is an Adjunct Professor of Biochemistry at the Institute for Molecular Medicine.

Joined IMM 1999.

 

Katherine A. Murray-Leisure, M.D.

Dr. Murray-Leisure is a graduate of Wellesley College, MA, and Harvard Medical School, Boston, MA. She is a board-certified specialist in internal medicine and infectious diseases. She served in various positions as specialist for infectious diseases in Gulf War Veterans and is currently Consultant Physician & Hospital epidemiologist at the Good Samaritan & Hyman Caplan Pavillon, Lebanon, PA. Dr. Murray-Leisure has been published 20 articles in medical journals, 5 abstracts from national and international conferences and 3 medical book chapters about infectious diseases. Dr. Leisure is an Adjunct Clinical Professor of Medicine at the Institute for Molecular Medicine.

Joined IMM 1999.

 

William Baumzweiger, M.D.

Dr. Baumzweiger received his B.A. from Brandeis University and his M.D. from State University of New York. He was a resident in psychiatry at Los Angeles County Hospital and a resident in neurology at the Wadsworth VA Medical Center in Los Angeles. He was previously an Assistant Clinical Professor at UCLA and the Coordinator of the Neuroscience Program at the Wadsworth VA Medical Center. He is a member of the American Psychiatric Association, Southern California Psychiatric Society and American Academy of Neurology. He is currently in private practice in Tarzana, California. Dr. Baumzweiger is an Adjunct Clinical Professor of Medeicine at the Institute for Molecular Medicine.

Joined IMM 2000.

 

Nachman Brautbar, M.D.

Dr. Brautbar is currently a Clinical Professor of Medicine at the University of Southern California and Vice-Chairman of the Department of Medicine, Queen of Angeles-Hollywood Presbyterian Medical Center in Los Angeles, CA. He obtained his M.D. at Hebrew University-Hadassah Medical School in Jerusalem, Israel in 1969. He did residencies in Israel and at the Wadsworth V.A. Medical Center in Los Angeles, CA. He joined the faculty of U.C.L.A. as an Assistant Professor of Medicine in 1977 and then as an Assistant Professor of Medicine at U.S.C. He was a tenured Associate Professor of Medicine at U.S.C. before going into private practice. He is a member of 45 national and international professional societies and is currently a Diplomate of the American Board of Forensic Medicine, the American Board of Internal Medicine, American Board of Nephrology, American College of Occupational & Environmental Medicine. Among his awards are the Fellow of the Collegium Ramazzini and Fellow of the American College of Physicians. He has published over 220 medical and scientific papers, reviews and book chapters and serves on 9 editorial boards and is the Editor-in-Chief of the International Journal of Occupational Medicine and Toxicology and the Journal of Clean Technology, Environmental Toxicology and Occupational Medicine. He is also the Co-Editor of Toxicology and Industrial Health. Dr. Brautbar is an Adjunct Professor of Medicine at the Institute for Molecular Medicine.

Joined IMM in 2001.

 

Parsotam Ravjee Hira, M.Sc., Ph.D.

Dr. Hira is a Professor of Microbiology at Kuwait University Faculty of Science. He obtained his B.Sc. from the University of South Africa in 1962, a M.Sc. in parasitology from the University of Ibadan, Nigeria in 1966 and his Ph.D. in the same subject from the University of South Africa in 1970. He also received a M.Sc. in medical parasitology from the University of London School of Hygiene and Tropical Medicine. Dr. Hira is a fellow of the Royal College of Pathologists (MCRPath) and a Diplomate of the American Board of Medical Microbiology and a Diplomate of the London School of Tropical Medicine. He has held various academic positions before moving to the University of Kuwait in 1981. In 1992 he became a full Professor in the Department of Microbiology at the University of Kuwait. He also serves on important committees in the Ministry of Health of Kuwait. Dr. Hira is a specialist on malaria and other parasitic diseases and has published approximately 100 scientific papers on the subject since 1965. Dr. Hira is an Adjunct Professor of Microbiology at the Institute for Molecular Medicine and a consultant in parasitology and tropical medicine.

Joined IMM in 2001.


H. Linsey Arison, III, M.S., Ph.D.

Dr. Arison is currently the Director of Education and Training, C4 Systems Directorate, Joint Chiefs of Staff (J-6), U. S. Department of Defense, The Pentagon, Washington D.C. He was previously the Director, Program Integration for the Assistant Secretary of Defense for Reserve Affairs. He obtained his B.S. degree from the U.S. Military Academy at West Point in 1973. He holds M.S. degrees in Systems Management from University of Southern California (1981) and Public Administration from Harvard University (1985). He received his Ph.D. from the University of Wales, Cardiff in 2001. Dr. Arison is currently the U. S. Representative to the NATO C3 Board Ad Hoc Working Group on NATO Interoperability Management Plan. Mr. Arison retired from active and then reserve duty as a Colonel after assignments in Fort Benning, Fort Bragg, Fort Sill, among others and the U.S. Military Academy. When he retired from the U.S. Army reserves, he was Acting Commander of the Capitol Hill reserve detachment in Washington DC. Dr. arison is an Adjunct Associate Professor at the Institute for Molecular Medicine and a consultant on military affairs.

Joined IMM in 2001.

 

Meryl Nass, M.D.
Dr. Nass is in private practice in Freeport, Maine and on the medical staff of Parkview Hospital, Brunswick, ME. She received her B.S. in Biology from the Massachusetts Institute of Technology (1974) and her M.D. from the University of Missippi Medical School (1980). She specializes in the treatment of Chronic Fatigue Syndrome, Fibromyalgia Syndrome and Gulf War Illnesses. Dr. Nass has published over 20 articles in medical and scientific journals. She is a national expert in the field of anthrax and biological warfare. She was the first scientist to realize that Zimbabwe's anthrax epidemic of 1978-80 was not a natural event, and proved it in 1992. As a consultant to Cuba's Ministry of Health, she correctly diagnosed the cause of a neuropathy epidemic affecting 50,000 Cubans. She has developed a model for evaluating epidemics to determine the likelihood that they are due to bioterrorism. She was the first researcher to point out the relationship between anthrax vaccine and Gulf War Illnesses, and has been very active in identifying the role of this vaccine in a variety of chronic medical illnesses. Dr. Nass is an Adjunct Clinical Associate Professor of Medicine at the Institute for Molecular Medicine.

Joined IMM 2001.

 

Garry Gordon, M.D., D.O., M.D.(H.)

Dr. Gordon is the President of the Gordon Research Institute in Payson, Arizona. He received his Doctor of Osteopathy from the Chicago College of Osteopathy in Illinois (1958) and his M.D. (Hon.) from the University of California, Irvine (1962). He completed his Radiology Residency at Mt. Zion in San Francisco. For many years, he was the Medical Director of the Mineral Lab in Hayward, CA, a leading laboratory for trace mineral analysis. Dr. Gordon is on the Board of Homeopathic Medical Examiners for Arizona and is Co-Founder of the American College for Advancement in Medicine (ACAM). He is Founder/President of the International College of Advance Longevity (ICALM) and Board Member of International Oxidative Medicine Association (IOMA). He is an advisor to the American Board of Chelation Therapy and past instructor and examiner for all chelation physicians. He is responsible for peer review for Chelation Therapy in the State of Arizona. He lectures extensively on the End of Bypass Surgery and has published over 20 articles on this and other topics. Currently, Dr. Gordon is full-time consultant for Longevity Plus, a nutritional supplement company located in Payson, Arizona. He is responsible for the design of the majority of their supplements, which are widely used by alternative health practitioners around the world. Dr. Gordon is an Adjunct Clinical Professor of Medicine at the Institute for Molecular Medicine.

Joined IMM 2001.

 

Sanjay Dhar, M.Sc., Ph.D.

B.Sc., Chemistry, Zoology and Botany, University of Kashmir, Kashmir, India (1982). M.Sc., Zoology, University of Kashmir, Kashmir, India (1984). Ph.D., Molecular Parasitology, University of Kashmir, Kashmir, India (1993).

Dr. Dhar is a member of the Research and Development team at International Molecular Diagnostics, Inc. and a Research Assistant Professor of Molecular Biology at the Institute for Molecular Medicine. He has over 10 years of research experience in molecular biology and biochemistry; mainly in the area of molecular parasitology. He conducted his post-doctoral fellowship at Jawaharlal Neru University of New Delhi, India and was a Fogarty Fellow at the Center for Biologics and Evaluation & Research, Food and Drug Administration, NIH, Bethesda, MD. Prior to Joining IMD and IMM, Dr. Dhar was a research scientist in the Department of Cancer Biology at the New England Medical Center in Boston where he worked on breast cancer associated genes and gene expression in breast cancer.

Joined IMM in 2001

 

David H. Cribbs, Ph.D.

Ph.D. Biochemistry, University of West Virginia (1980); B.S. Biology, St. Mary's College of Maryland (1974)

Dr. Cribbs is an Associate Professor of Neurology at the University of California, Irvine, and Institute for Brain Aging and Dementia, a position he has held since 1999. He was previously an assistant professor at UCIrvine and the Johns Hopkins University. Dr. Cribbs was previously a NIH postdoctoral fellow at Johns Hopkins, and he was an American Society for Engineering Education Fellow at the Naval Research Laboratory from 1989-1993. Dr. Cribbs has published over 50 papers in scientific journals and is currently a member of the NIH Study Section on Cell Death and Injury in Neurodegeneration. Dr. Cribbs is an expert on neurodegeneration, Alzheimer's Disease and dementia. Dr. Cribbs is an Adjunct Associate Professor at the Institute for Molecular Medicine.

Joined IMM 2003


Top of the page